In bladder cancer, circZNF609 enhances fatty acid uptake via the IGF2BP2/CD36 pathway, leading to metabolic reprogramming that reduces tumor sensitivity to immunotherapy (40). Here, IGF2BP2 is linked to urinary bladder cancer.